Medical Therapies Limited

ASX:MTY ISIN:AU000000MTY8

May 27, 2012

	Medical Therapies Limited (ASX:MTY) Announce Positive Interim Results From Cuprindo Phase I Clinical Trials FEB 15, 2008 14:07 - Article Views: 1,423 Medical Therapies Limited (ASX: MTY), today announced that it has completed its 'first-in-human' clinical trial of Cuprindo(tm) to determine its safety, tolerability and systemic absorption characteristics. The Phase 1 trial was conducted using a topical suppository formulation in preparation for a planned efficacy study in proctitis patients.

	Medical Therapies Limited ASX: MTY - Investor Presentation - Ms Maria Halasz , MD and CEO JUNE 14, 2007 14:02 - Article Views: 476 Medical Therapies Limited (ASX: MTY) - Investor Presentation - Ms Maria Halasz , MD and CEO; Boardroomradio is pleased to announce that Medical Therapies Limited (ASX: MTY) has published an audio file.